Requena Elily Dianet Apumayta, Ocrospoma Danery Valdez, Ruiz Jhonatanael Salvador, De la Guerra Pancorvo Alberto, Kajatt Edgar Amorin
Surgical Oncology Resident, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
https://orcid.org/0000-0002-1828-7009.
Ecancermedicalscience. 2023 Jun 15;17:1559. doi: 10.3332/ecancer.2023.1559. eCollection 2023.
To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL).
This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000-2019 at Instituto Nacional de Enfermedades Neoplásicas in Lima, Perú.
73.9% of patients were male. Cough (78.3%) and weight loss (56.5%) were the most frequent clinical features. Dyspnoea and elevated values of DHL and B2 microglobulin were frequently altered in advanced stages. Diffuse large B cell lymphoma (DLBCL) represented 47.8% of the cases and the most common radiologic alterations were a mass (60%) and consolidation with air bronchogram (60%). The most utilised treatment was chemotherapy alone (60%). Three patients received only surgery. Median survival was 30 months. Five overall survival was 45%, and up to 60% in the case of mucosa-associated lymphoid tissue lymphoma.
PPL is infrequent. Clinical features are unspecific and the principal finding is a mass, nodule or consolidation with air bronchogram. Definitive diagnosis needs biopsy and immunohistochemistry. There is no standard treatment, it depends on histology type and stage.
描述原发性肺淋巴瘤(PPL)患者的临床特征、影像学表现、病理及治疗情况。
本病例系列研究对2000年至2019年间在秘鲁利马国家肿瘤研究所诊断为PPL的24例患者进行回顾性分析。
73.9%的患者为男性。咳嗽(78.3%)和体重减轻(56.5%)是最常见的临床特征。晚期患者常出现呼吸困难以及乳酸脱氢酶(DHL)和β2微球蛋白值升高。弥漫性大B细胞淋巴瘤(DLBCL)占病例的47.8%,最常见的影像学改变是肿块(60%)和伴有空气支气管征的实变(60%)。最常用的治疗方法是单纯化疗(60%)。3例患者仅接受了手术。中位生存期为30个月。总体生存率为45%,黏膜相关淋巴组织淋巴瘤患者的生存率高达60%。
PPL较为罕见。临床特征不具特异性,主要表现为肿块、结节或伴有空气支气管征的实变。确诊需要活检和免疫组化。目前尚无标准治疗方案,治疗方案取决于组织学类型和分期。